Literature DB >> 25285232

Reprogramming immune responses via microRNA modulation.

Juan R Cubillos-Ruiz1, Melanie R Rutkowski2, Julia Tchou3, Jose R Conejo-Garcia2.   

Abstract

It is becoming increasingly clear that there are unique sets of miRNAs that have distinct governing roles in several aspects of both innate and adaptive immune responses. In addition, new tools allow selective modulation of the expression of individual miRNAs, both in vitro and in vivo. Here, we summarize recent advances in our understanding of how miRNAs drive the activity of immune cells, and how their modulation in vivo opens new avenues for diagnostic and therapeutic interventions in multiple diseases, from immunodeficiency to cancer.

Entities:  

Keywords:  adaptive immunity; immunotherapy; microRNA; tumor immunology

Year:  2013        PMID: 25285232      PMCID: PMC4183223          DOI: 10.2478/micrnat-2013-0001

Source DB:  PubMed          Journal:  Microrna Diagn Ther


  103 in total

1.  A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

Authors:  Francesco Fazi; Alessandro Rosa; Alessandro Fatica; Vania Gelmetti; Maria Laura De Marchis; Clara Nervi; Irene Bozzoni
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

2.  MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis.

Authors:  Mathias Oertli; Daniela B Engler; Esther Kohler; Manuel Koch; Thomas F Meyer; Anne Müller
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

4.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

5.  The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ.

Authors:  Feng Ma; Sheng Xu; Xingguang Liu; Qian Zhang; Xiongfei Xu; Mofang Liu; Minmin Hua; Nan Li; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-07-24       Impact factor: 25.606

6.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

7.  Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.

Authors:  Sanjay Swaminathan; Kazuo Suzuki; Nabila Seddiki; Warren Kaplan; Mark J Cowley; Chantelle L Hood; Jennifer L Clancy; Daniel D Murray; Catalina Méndez; Linda Gelgor; Ben Anderson; Norman Roth; David A Cooper; Anthony D Kelleher
Journal:  J Immunol       Date:  2012-05-14       Impact factor: 5.422

8.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

9.  Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.

Authors:  Florence Allantaz; Donavan T Cheng; Tobias Bergauer; Palanikumar Ravindran; Michel F Rossier; Martin Ebeling; Laura Badi; Bernhard Reis; Hans Bitter; Matilde D'Asaro; Alberto Chiappe; Sriram Sridhar; Gonzalo Duran Pacheco; Michael E Burczynski; Denis Hochstrasser; Jacky Vonderscher; Thomas Matthes
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

10.  microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.

Authors:  Elena Vigorito; Kerry L Perks; Cei Abreu-Goodger; Sam Bunting; Zou Xiang; Susan Kohlhaas; Partha P Das; Eric A Miska; Antony Rodriguez; Allan Bradley; Kenneth G C Smith; Cristina Rada; Anton J Enright; Kai-Michael Toellner; Ian C M Maclennan; Martin Turner
Journal:  Immunity       Date:  2007-12-06       Impact factor: 31.745

View more
  2 in total

1.  Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).

Authors:  Adi Vaknin-Dembinsky; Hanna Charbit; Livnat Brill; Oded Abramsky; Devorah Gur-Wahnon; Iddo Z Ben-Dov; Iris Lavon
Journal:  J Neuroinflammation       Date:  2016-07-08       Impact factor: 8.322

2.  Bystander T-Cells Support Clonal T-Cell Activation by Controlling the Release of Dendritic Cell-Derived Immune-Stimulatory Extracellular Vesicles.

Authors:  Marthe F S Lindenbergh; Daniëlle G J Koerhuis; Ellen G F Borg; Esther M van 't Veld; Tom A P Driedonks; Richard Wubbolts; Willem Stoorvogel; Marianne Boes
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.